Use of peptide compounds for treating bone cancer pain, chemotherapy-and nucleoside-induced pain

Details for Australian Patent Application No. 2005276634 (hide)

International Classifications

Event Publications

15 March 2007 PCT application entered the National Phase

PCT publication WO2006/021412 Priority application(s): WO2006/021412

3 March 2011 Alteration of Name

The name of the applicant has been altered to UCB Pharma GmbH

24 March 2011 Application Accepted

Published as AU-B-2005276634

21 July 2011 Standard Patent Sealed

22 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.